Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Associate Partners:

  • Kotak Mutual Fund
  • Pharmeasy
  • Indiabulls
  • SBI

Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Technology Partner

Dell Technologies

Associate Partners

Kotak Mutual Fund
Pharmeasy
Indiabulls
SBI
UPCOMING EVENT:Are you 45+? Planning for retirement? We have just the right webinar for you - Planning for Retirement with Life Insurance on 27-Jan, 3pm. Register now!

Bafna Pharma Standalone June 2021 Net Sales at Rs 21.26 crore, up 27.28% Y-o-Y

August 05, 2021 / 06:47 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Bafna Pharmaceuticals are:

Net Sales at Rs 21.26 crore in June 2021 up 27.28% from Rs. 16.70 crore in June 2020.

Quarterly Net Profit at Rs. 2.09 crore in June 2021 up 15.2% from Rs. 1.81 crore in June 2020.

EBITDA stands at Rs. 3.65 crore in June 2021 up 31.29% from Rs. 2.78 crore in June 2020.

Bafna Pharma EPS has decreased to Rs. 0.88 in June 2021 from Rs. 7.66 in June 2020.

Close

Bafna Pharma shares closed at 155.25 on August 04, 2021 (NSE) and has given 31.07% returns over the last 6 months

Bafna Pharmaceuticals
Standalone Quarterly Resultsin Rs. Cr.
Jun'21Mar'21Jun'20
Net Sales/Income from operations21.2621.8416.70
Other Operating Income------
Total Income From Operations21.2621.8416.70
EXPENDITURE
Consumption of Raw Materials13.6210.1610.76
Purchase of Traded Goods------
Increase/Decrease in Stocks-0.542.490.94
Power & Fuel------
Employees Cost3.263.921.79
Depreciation1.461.500.95
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses1.441.070.61
P/L Before Other Inc. , Int., Excpt. Items & Tax2.022.701.65
Other Income0.170.310.18
P/L Before Int., Excpt. Items & Tax2.193.011.83
Interest0.110.380.02
P/L Before Exceptional Items & Tax2.092.641.81
Exceptional Items------
P/L Before Tax2.092.641.81
Tax------
P/L After Tax from Ordinary Activities2.092.641.81
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period2.092.641.81
Equity Share Capital23.6623.662.37
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS0.881.117.66
Diluted EPS0.881.117.66
EPS After Extra Ordinary
Basic EPS0.881.117.66
Diluted EPS0.881.117.66
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

Sections
ISO 27001 - BSI Assurance Mark